Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0001045969-00-000206
Filing Date
2000-03-24
Accepted
2000-03-24 00:00:00
Documents
9
Period of Report
1999-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K 10-K405 116480
2 1999 NONEMPLOYEE DIRECTOR STOCK OPTION PLAN EX-10.7 15483
3 WILLIAM C. BROWN TERMINATION AGREEMENT EX-10.18 24411
4 LEON O. MOULDER, JR. TERMINATION AGREEMENT EX-10.19 24474
5 1999 ANNUAL REPORT TO SHAREHOLDERS EX-13 105725
6 INDEPENDENT AUDITORS CONSENT EX-23 1047
7 POWER OF ATTORNEY EX-24 3066
8 FINANCIAL DATA SCHEDULE EX-27 2363
9 CAUTIONARY STATEMENTS EX-99 43004
  Complete submission text file 0001045969-00-000206.txt   338505
Mailing Address OPUS CENTER 9900 BREN ROAD EAST SUITE 300E MINNEAPOLIS MN 55343
Business Address 9900 BREN RD EAST STE 300E C/O OPUS CENTER MINNETONKA MINNESOTA MINNEAPOLIS MN 55343 6129357335
MGI PHARMA INC (Filer) CIK: 0000702131 (see all company filings)

EIN.: 411364647 | State of Incorp.: MN | Fiscal Year End: 1231
Type: 10-K405 | Act: 34 | File No.: 000-10736 | Film No.: 577187
SIC: 2834 Pharmaceutical Preparations